Makaleler
72
Tümü (72)
SCI-E, SSCI, AHCI (53)
SCI-E, SSCI, AHCI, ESCI (60)
ESCI (7)
Scopus (64)
TRDizin (15)
3. Bone matters: Ga-68 PSMA PET/CT volumetrics predict PSA-PFS and OS in bone-dominant mCRPC patients treated with [¹⁷⁷Lu]Lu-PSMA-617
European Journal of Nuclear Medicine and Molecular Imaging
, cilt.53, sa.3, ss.1822-1835, 2026 (SCI-Expanded, Scopus)
26. Do metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?
Joint Diseases and Related Surgery
, cilt.35, sa.1, ss.105-111, 2023 (SCI-Expanded, Scopus, TRDizin)
29. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
European Journal of Clinical Pharmacology
, cilt.78, sa.12, ss.1973-1979, 2022 (SCI-Expanded, Scopus)
34. The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Journal of Cancer Research and Clinical Oncology
, cilt.147, sa.9, ss.2637-2643, 2021 (SCI-Expanded, Scopus)
37. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Journal of Cancer Research and Clinical Oncology
, cilt.147, sa.7, ss.2145-2152, 2021 (SCI-Expanded, Scopus)
57. Current Treatment Options for Metastatic Pancreatic Adenocarcinoma
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.25, sa.4, ss.263-274, 2015 (SCI-Expanded, Scopus, TRDizin)
61. TÜRKİYE DE ONKOLOJİ HASTALARININ BİYOPSİKOSOSYAL VE KOZMİK İHTIYAÇLARI
Turkiye Klinikleri Journal of Psychiatry Special Topics
, cilt.7, sa.4, ss.1-4, 2014 (TRDizin)
65. Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.20, ss.8715-8718, 2014 (SCI-Expanded, Scopus)
67. Lung Cancer Screening: A Comprehensive Review of the Literature with Detailed Data
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.270-278, 2014 (SCI-Expanded, Scopus, TRDizin)
68. Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.13, ss.5337-5341, 2014 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
94
1. A case of hypophysitis with panhypopituitarism after the use of the immune check point inhibitor pembrolizumab
Endobridge 2021, 21 Ekim 2021
3. The investigation of the related factors that affected targeted therapy outcome in metastatic colon cancer
10th International Gastrointestinal Cancer Conference, 2-6 December 2020., Türkiye, 02 Aralık 2020, (Özet Bildiri)
4. The incidence and prognostıc significance of sarcopenia in advanced gastric cancer patients
10th International Gastrointestinal Cancer Conference, 2-6 December 2020., Türkiye, 2 - 06 Aralık 2020, (Özet Bildiri)
9. Current Treatment Options in 2nd line Gastric Cancer and Ramucirumab
9th Internatıonal Gastrointestinal Cancer Conference, 6 - 08 Aralık 2019, (Tam Metin Bildiri)
10. Give Her a long Life with Ribociclib in HR HER- aBC
6th congress of the mediterranean multidisciplinary oncology forum, 28 Kasım - 01 Aralık 2019, (Tam Metin Bildiri)
11. EFFİCACY AND SUCCESS OF AF ABLATİON İN CANCER PATİENTS
3.ULUSAL İMMİNOTERAPİ VE ONKOLOJİ KONGRESİ, Türkiye, 30 Ekim - 03 Kasım 2019, (Özet Bildiri)
12. Timing of ADT in the Era of Stampede and Latitude
World Urological Oncology Federation Symposium, 17 Ekim 2019, (Tam Metin Bildiri)
13. Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi
23. Ulusal Kanser Kongresi - 2019, Türkiye, 17 - 21 Nisan 2019, (Özet Bildiri)
14. Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi
23. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.185, (Özet Bildiri)
15. GERIATRIK (≥75 YAŞ), KASTRASYON DIRENÇLI METASTATIK PROSTAT KANSERI (KDMPK) HASTALARINDA 1. BASAMAK ANTI- ANDROJEN TEDAVI SONUÇLARI- GERÇEK YAŞAM VERISI
23. ULUSAL KANSER KONGRESİ - 2019, Türkiye, 17 - 21 Nisan 2019, (Tam Metin Bildiri)
16. GERİATRİK (≥75 YAŞ), KASTRASYON DİRENÇLİMETASTATİK PROSTAT KANSERİ (KDMPK)HASTALARINDA 1. BASAMAK ANTİ- ANDROJENTEDAVİ SONUÇLARI- GERÇEK YAŞAM VERİSİ
23. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.300, (Özet Bildiri)
18. COMBINATION OF OxALIPLATIN, CAPECITABINE,t r a s t u z u m a b a n d c h e m o r a d io t h e r a p y INPATIENTS WITH GASTRIC CANCER
8 th INTERNATIONALGASTROINTESTINALCANCER CONFERENCE, 7 - 09 Aralık 2018, (Tam Metin Bildiri)
20. Neoadjuvant Treatment of Bladder Cancer
8th Eurasian Uro-oncology Congress, 28 Haziran - 01 Temmuz 2018, (Tam Metin Bildiri)
22. Case report: management of a patient with malignant insulinoma
20th European Congress of Endocrinology, 19 - 22 Mayıs 2018, (Özet Bildiri)
23. Detection of pulmonary metastases with 18F-Fluorocholine PET/CT and treatment of refractory hypercalcemia with denosumab in a patient with long term parathyroid carcinoma
20th European Congress of Endocrinology, 19 - 22 Mayıs 2018, (Özet Bildiri)
25. Metastatik Pankreas Kanserinde 2. Basamak Tedavilerin Etkinliği
7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, (Özet Bildiri)
26. Metastatik Pankreas Kanserinde İkinci Basamak Tedavi Öncesi Prognostik Belirteçlerin Saptanması
7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, (Özet Bildiri)
27. The Role of Dynamic Serum Thiol-Disulphide Homeostasis in Metastatic Gastric Cancer
7TH INTERNATIONAL GASTROINTESTINAL CANCERS CONFERENCE, İstanbul, Türkiye, 15 - 17 Aralık 2017, (Özet Bildiri)
28. Evaluation of dynamic serum thiol disulphide homeostasis in colorectal cancer
7th International Gastrointestinal Cancers Conference, 15 - 17 Aralık 2017, (Tam Metin Bildiri)
29. Young oncologists asking experts answering
7th International Gastrointestinal Cancers Conference, 15 - 17 Aralık 2017, (Tam Metin Bildiri)
30. Assesment of nutritional status in cancer patients
7th International Gastrointestinal Cancers Conference, 15 - 17 Aralık 2017, (Tam Metin Bildiri)
31. Tyrosine kinase inhibitors (TKI): Awareness of drug-drug interaction
42nd ESMO Congress (ESMO 2017), 8 - 12 Eylül 2017, (Tam Metin Bildiri)
33. ilERi EvRE koloREktal kanSERlERdE RdW-platElEt oRanInIn pRognoStik önEMi
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
34. t790M MutaSyonu pozitiF akciğER kanSERindE oSiMERtiniB diREnci; olgu SunuMu
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
36. özEFaguS yaSSI HÜcREli kaRSinoMlaRda lokal tEdavi StRatEjilERi vE pRognoStik FaktöRlER
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
38. 2016 yIlInda tÜRkiyE kaynaklI onkolojik yayInlaR
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
39. MEtaStatik vE nEoadjuvant tEdavi alan tRanSizyonEl HÜcREli MESanE kanSERindE HuMan EquiliBRativE nuclEoSidE tRanSpoRtER 1 (HEnt1) MolEkÜlÜnÜn pREdiktiF vE pRognoStik önEMinin dEğERlEndiRilMESi
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
40. FREQUENCY OF CHEMOTHERAPY INDUCED AMENORRHEA IN WOMEN WITH COLORECTALCANCER
International Congress on Oncological Sciences, 27 Eylül - 01 Ekim 2017, (Özet Bildiri)
41. Prognostıc importance red cell dısturbatıon wıdth to platelet ratio in advanced colorectal cancer
6th international Gastrointestinal cancer conferance December 2016 Antalya, Turkey, 2 Kasım - 06 Aralık 2016
42. Prognostic significance of reziduel tumor size after chemoradiotherapy for rectal adenocarcinoma
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016
43. EFFECT OF RED CELL DISTURBATION WIDTH TO PLATELET RATIO ONDISEASE FREE SURVIVAL IN EARLY STAGE COLORECTAL CANCER
6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 Aralık 2016
44. Tumor size in early stage N0 gastric carsinoma is it prognostic
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016
45. Local treatment strategies for esophageal SCC and prognostiıc factors
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Tam Metin Bildiri)
46. Rituximab for primary extranodal lymphomas effectiveness
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Tam Metin Bildiri)
47. METASTATIC COLORECTAL CANCER SURVIVAL IS THERE A DIFFERENCEBETWEEN SYNCHRONOUS OR METACHRONOUS TUMORS
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016
48. EFFECT OF THE RAS STATUS ON SURVIVAL IN ADVANCED COLON CANCER
6th InternatIonal GastroIntestInal CanCer ConferenCe, 2 - 04 Aralık 2016
49. PROGNOSTIC IMPORTANCE RED CELL DISTURBATION WIDTH TOPLATELET RATIO IN ADVANCED COLORECTAL CANCER
6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 Aralık 2016
50. THE NEUTROPHIL LYMPHOC YTE RATIO MAY HAVE PROGNOSTICEFFECT IN THE METASTATIC COLORECTAL CANCER
6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 Aralık 2016
51. THE PROGNOSTIC FACTORS IN STAGE 3 COLORECTAL CANCER PATIENTS
6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 Aralık 2016
52. Prognostic significance of rezidual tumor size after chemoradiotherapy for rectal adenocarcinoma
6th international gis conference, 2 - 04 Aralık 2016, (Özet Bildiri)
53. Gastric cancer with lung metastasis and concurrent miliary tuberculosis
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Özet Bildiri)
54. A rare case metastatic anal cloacogenic transitional cell carcinoma
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Özet Bildiri)
55. ASSESSMENT OF THE COST EFFECTIVENESS OF THE FIRST LINE TARGETED THERAPIES FOR ADVANCED COLON CANCER IN TURKEY
6,International gastrointestinal cancer confrence, 2 - 04 Aralık 2016
56. Compare tumor features and survival in right sided and left sided early stage colorectal cancer
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Özet Bildiri)
57. Metastatic colorectal cancer survival İs there a difference between synchronous or metachronous tumors
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Özet Bildiri)
58. Effects of neutrophil lymphocyte ratio and platelet lymphocyte ratio on survival of non metastatic colorectal cancer
6th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Özet Bildiri)
59. Association between tumor localisation and clinicopathological characteristics and survival of colorectal cancer
th International Gastrointestinal Cancers Conference, 2 - 04 Aralık 2016, (Özet Bildiri)
60. ASSOSCIATION BETWEEN TUMOR LOCALISATION AND CLINICOPATHOLOGICAL CHARACTERISTICS AND SURVIVAL OF COLORECTAL CANCER
6,International gastrointestinal cancer confrence, 2 - 04 Aralık 2016
61. Local treatment stratejies for esophageal scc and prognostic factors
6th international gis conference, 02 Aralık 2016, (Özet Bildiri)
63. Association between tumor localisation andClinicopathologic characteristics and survival of colorectal cancer
6th international Gastrointestinal cancer conferance December 2016 Antalya, Turkey, 2 - 06 Kasım 2016
64. Effect of red cell disturbatıon width to platelet ratio on dısease free survival in early stage colorectal cancer
6th international Gastrointestinal cancer conferance December 2016 Antalya, Turkey, 2 - 06 Kasım 2016
65. Impact of vitamin D3 replacement therapy on clinical outcomes and survival rates in patients with early stage breast cancer
41st ESMO Congress (ESMO 2016), 7 - 11 Ekim 2016
66. Efficacy of statin usage before diagnosis on clinico pathological characteristics and outcome of invasive breast cancer Annals of Oncology
41st ESMO Congress (ESMO 2016), 7 - 11 Ekim 2016, (Özet Bildiri)
67. Prognosti role of tumor location in stage 3 colorectal cancer patients received adjuvant chemotherapy
ESMO 2016, 7 - 11 Ekim 2016, (Özet Bildiri)
68. Comparison of clinical outcomes in patents with early stage ER PR HER2 breast cancer patients with triple negatives
2016 ASCO Annual Meeting, 3 - 07 Haziran 2016
69. Adjuvant chemotherapy for esophageal scc
6th international gis conference, 2 - 04 Aralık 2016, (Özet Bildiri)
70. METASTATİK MALİGN MELANOMDA BİRİNCİ BASAMAK TEDAVİLERİN MALİYET ANALİZİ
6. Türk Tıbbi Onkoloji Kongresi, Türkiye, 23 - 27 Mart 2016, (Özet Bildiri)
71. METASTATİK KOLON KANSERİ HASTALARINDA BİRİNCİ BASAMAK HEDEFE YÖNELİK TEDAVİLERİN MALİYET ANALİZİ
6. Türk Tıbbi Onkoloji Kongresi, Türkiye, 23 - 27 Mart 2016, (Özet Bildiri)
72. A novel strategy for determining circulating tumour cells in lungcancer
10th ISMRC International Symposium on Minimal Residual Cancer Liquid Biopsy in Cancer Diagnostic and Treatment, Hamburg, Almanya, 19 - 21 Mart 2016, ss.73
73. A novel strategy for determining circulating tumour cells in lung cancer
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, Almanya, 19 - 21 Mart 2016, (Özet Bildiri)
74. A novel strategy for determining circulating tumour cells in lung cancer
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, 19 - 21 Mart 2016
75. The effect of body mass index in patients with relapsed colorectal cancer
5th İnternational Gastrointestinal Cancers Conference, 4-6 December 2015, İstanbul-Turkey., 4 - 06 Aralık 2015, (Özet Bildiri)
76. Multiple Akciğer ve Kemik Metastazı Yapan Deri Eki Tümörü
25.Ulusal Patoloji Kongresi, Türkiye, 14 - 17 Ekim 2015, (Özet Bildiri)
77. STUDY OF THE IMPACT OF CHARLSON COMORBIDITY INDEX ON THE EFFICACY OF ADJUVANT TRASTUZUMAB IN PATIENTS WITH HER 2 POSITIVE EARLY BREAST CANCER
18TH ECCO-40TH ESMO 2015, 25 - 29 Eylül 2015, (Tam Metin Bildiri)
78. The ef cacy and predictive factors of response of second line triplet modi ed EOX epirubicin oxaliplatin capacitabine regimen in metastatic gastric cancer
ESMO European Cancer Congress, 25 - 29 Eylül 2015, (Özet Bildiri)
79. The importance of thiol disulphide homeostasis in patients with advanced gastric cancer AGC receiving modi ed docetaxel and cisplatin plus uorouracil mDCF regimen
18th ECCO-40th ESMO European Cancer Congress 25-29 September 2015, Vienna, Austria, European Journal of Cancer, Volume 51, Supplement 3, September 2015, S468., 25 - 29 Eylül 2015, (Özet Bildiri)
80. Study of the impact of Charlson comorbidity index on the ef cacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer
18th ECCO-40th ESMO European Cancer Congress 25-29 September 2015, Vienna, Austria, European Journal of Cancer, Volume 51, Supplement 3, September 2015, S322, 25 - 29 Eylül 2015, (Özet Bildiri)
81. THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX IPI IN THEDETERMINATION OF PROGNOSIS OF EARLY STAGE DIFFUSE LARGE B CELLNON HODGKIN LYMPHOMA IS IT ENOUGH
18TH ECCO-40TH ESMO 2015, 25 - 29 Eylül 2015, (Tam Metin Bildiri)
82. Tumor locations significantly affect disease free survival and overall survival
2015 ASCO Annual Meeting, J Clin Oncol 33, 2015 (suppl; abstr e12590)., 30 Mayıs - 03 Haziran 2015, (Özet Bildiri)
85. Erişkin hastalarda nazofarenks kanseri olgularının retrospektif değerlendirilmesi Tek merkez deneyimi
21. Ulusal Kanser Kongresi, 22-26 Nisan 2015, Antalya, Türkiye, 22 - 26 Nisan 2015
86. KEMOTERAPİ HAZIRLAMA VE UYGULAMA SIRASINDA ORTAYA ÇIKAN TIBBİ HATALAR KEMOTERAPİ HEMŞİRELERİ ARASINDA YAPILAN ÇOK MERKEZLİ ANKET ÇALIŞMASI
21. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 22 - 26 Nisan 2015
87. Onkoloji polikliniğine başvuran hastalarda idrar inkontinansı sıklığı ve yaşam kalitesi üzerine etkisinin incelenmesi
21. Ulusal Kanser Kongresi, 22-26 Nisan 2015, Antalya, Türkiye, 22 - 26 Nisan 2015
88. 2014 Yılı Türkiye Kaynaklı Onkolojik Yayınların Tüm Yayınlar İçindeki Yeri Ve Önemi
21. UlusalKanser Kongresi, Türkiye, 16 - 20 Nisan 2015
92. Refrakter germ hücreli testis tümöründe paklitaksel ifosfamid ve cisplatin tedavisi sonrasında gelişen trombotik trombositopenik purpura Olgu sunumu ve literatürün gözden geçirilmesi
11. Ulusal Tıbbi Onkoloji Kongresi (UTOK), 17-21 Eylül 2014, KKTC, Türkiye, 17 - 21 Eylül 2014
93. DIAGNOSIS TREATMENT CHARACTERESTICS AND COMORBIDITY OF WOMEN OF BREAST CANCER AGED 65 AND OLDER VERSUSU 80 AND OLDER
THE AMERICAN GERIATRIC SOCIETY 2014 ANUAL SCIENTIFIC MEETING, 15 Mayıs 2014, (Tam Metin Bildiri)
94. Efficacy of adjuvant tamoxifen in hormone receptor positive premenopausal breast cancer patients according to the body mass index
2014 San Antonio Breast Cancer Symposium, 9 - 13 Aralık 2014
Kitaplar
8
2. Solunum sistemi muayenesi.
Erişkinlerde Anamnez ve Fizik Muayene, OSMAN ERSOY, ÖYKÜ TAYFUR YÜREKLİ, MEHMET ALİ NAHİT ŞENDUR, Editör, ANKARA NOBEL TIP KİTABEVİ, Ankara, ss.59-78, 2019
3. İmmünoterapilerde Yan Etki Yönetimi
İmmünoterapilerin Advers Etkileri ve Yönetimi, İrfan Çiçin, Editör, Türkiye Klinikleri, ss.8-17, 2019
4. KALP MUAYENESİ
ERİŞKİNLERDE ANAMNEZ VE FİZİK MUAYENE, OSMAN ERSOY, Editör, ANKARA NOBEL TIP KİTABEVLERİ, Ankara, ss.97-126, 2019
5. Bazal hücreli kanserde güncel tedavi
Cilt kanserleri, , Editör, Türkiye Klinikleri, ss.72-76, 2019
6. Bazal Hücreli Kanserde Güncel Tedavi
Cilt Kanserleri, Umut Demirci, Editör, Türkiye Klinikleri, ss.72-76, 2019
7. Baş Boyun Muayenesi. Anamnez ve Fizik Muayene Kitabı.
Anamnez ve Fizik Muayene, Mehmet Ali Nahit Şendur, Muhammed Bülent Akıncı, Editör, Ankara Nobel Kitapevi, ss.33-52, 2019
8. Targeted Therapies and Immunotherapy in Bladder Cancer
Principles and Practice of UrooncologyRadiotherapy, Surgery and SystemicTherapy, Ozyigit, Gokhan, Selek, Ugur (Eds.), Editör, Springer, ss.141-152, 2017